Hayek Kallen Investment Management grew its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 2.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 13,886 shares of the company’s stock after buying an additional 302 shares during the quarter. Hayek Kallen Investment Management’s holdings in Colgate-Palmolive were worth $1,029,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in CL. Blue Chip Partners Inc. boosted its holdings in shares of Colgate-Palmolive by 0.4% during the first quarter. Blue Chip Partners Inc. now owns 1,805 shares of the company’s stock worth $132,000 after purchasing an additional 8 shares during the period. Cue Financial Group Inc. boosted its holdings in shares of Colgate-Palmolive by 0.3% during the second quarter. Cue Financial Group Inc. now owns 4,854 shares of the company’s stock worth $360,000 after purchasing an additional 14 shares during the period. Cornerstone Financial Partners LLC boosted its holdings in shares of Colgate-Palmolive by 0.5% during the second quarter. Cornerstone Financial Partners LLC now owns 3,813 shares of the company’s stock worth $282,000 after purchasing an additional 19 shares during the period. M Holdings Securities Inc. boosted its holdings in shares of Colgate-Palmolive by 0.4% during the first quarter. M Holdings Securities Inc. now owns 5,366 shares of the company’s stock worth $393,000 after purchasing an additional 21 shares during the period. Finally, Capital Investment Advisors LLC boosted its holdings in shares of Colgate-Palmolive by 0.3% during the second quarter. Capital Investment Advisors LLC now owns 8,318 shares of the company’s stock worth $617,000 after purchasing an additional 27 shares during the period. 73.45% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Company (CL) opened at 69.20 on Tuesday. Colgate-Palmolive Company has a 12-month low of $63.43 and a 12-month high of $77.27. The stock has a market capitalization of $60.95 billion, a price-to-earnings ratio of 25.72 and a beta of 0.81. The stock’s 50 day moving average is $72.72 and its 200 day moving average is $73.10.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, October 27th. The company reported $0.73 earnings per share for the quarter, hitting the consensus estimate of $0.73. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The firm had revenue of $3.97 billion during the quarter, compared to analysts’ expectations of $3.94 billion. During the same quarter in the prior year, the company earned $0.73 EPS. The company’s revenue was up 2.8% compared to the same quarter last year. Equities analysts predict that Colgate-Palmolive Company will post $2.89 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, November 15th. Stockholders of record on Monday, October 23rd will be given a $0.40 dividend. The ex-dividend date of this dividend is Friday, October 20th. This represents a $1.60 annualized dividend and a dividend yield of 2.31%. Colgate-Palmolive’s payout ratio is presently 61.78%.

A number of research firms have recently weighed in on CL. SunTrust Banks, Inc. upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and increased their target price for the stock from $65.00 to $85.00 in a report on Wednesday, October 11th. Stifel Nicolaus set a $73.00 target price on shares of Colgate-Palmolive and gave the stock a “hold” rating in a report on Sunday. Royal Bank Of Canada reiterated a “hold” rating and set a $74.00 target price on shares of Colgate-Palmolive in a report on Sunday, October 8th. Zacks Investment Research lowered shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Thursday, July 27th. Finally, BidaskClub lowered shares of Colgate-Palmolive from a “sell” rating to a “strong sell” rating in a report on Wednesday, July 12th. One research analyst has rated the stock with a sell rating, fifteen have given a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of $76.79.

WARNING: This article was originally reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this article on another site, it was copied illegally and republished in violation of United States & international copyright and trademark laws. The legal version of this article can be read at https://theolympiareport.com/2017/10/31/hayek-kallen-investment-management-buys-302-shares-of-colgate-palmolive-company-cl.html.

In other news, insider Patricia Verduin sold 3,833 shares of the company’s stock in a transaction that occurred on Tuesday, August 15th. The shares were sold at an average price of $71.45, for a total value of $273,867.85. Following the completion of the sale, the insider now owns 53,173 shares of the company’s stock, valued at approximately $3,799,210.85. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Dennis J. Hickey sold 73,872 shares of the company’s stock in a transaction that occurred on Thursday, August 3rd. The stock was sold at an average price of $71.80, for a total transaction of $5,304,009.60. Following the completion of the sale, the chief financial officer now directly owns 484,985 shares of the company’s stock, valued at approximately $34,821,923. The disclosure for this sale can be found here. Insiders sold a total of 126,705 shares of company stock valued at $9,080,117 in the last ninety days. Corporate insiders own 1.02% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with Analyst Ratings Network's FREE daily email newsletter.